berberine has been researched along with lovastatin in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (10.00) | 29.6817 |
| 2010's | 13 (65.00) | 24.3611 |
| 2020's | 5 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Sashidhara, KV; Singh, SP | 1 |
| Golab, J; Issat, T; Jakóbisiak, M | 1 |
| Berge, KE; Cameron, J; Kulseth, MA; Leren, TP; Ranheim, T | 1 |
| Bil, J; Golab, J; Issat, T; Jakobisiak, M; Nowis, D; Winiarska, M | 1 |
| Carlomagno, G; Fazio, S; Mercurio, V; Pirozzi, C; Ruvolo, A | 1 |
| Borghi, C; Cicero, AF; Grandi, E; Morbini, M; Parini, A; Reggi, A; Rosticci, M | 1 |
| Esposito, G; Izzo, R; Manzi, MV; Rozza, F; Santoro, M; Schiattarella, GG; Serino, F; Stabile, E; Trimarco, B; Trimarco, V | 1 |
| Chen, Y; Feng, R; Fu, J; Gao, X; Guo, F; He, CY; Huang, M; Jiang, JD; Li, XY; Luo, SH; Ma, C; Ren, L; Shou, JW; Wang, Y; Wen, BY; Zhao, ZX | 1 |
| Bisen, PS; Bundela, S; Sharma, A | 1 |
| Cui, H; Dang, M; Dong, Y; Liu, H; Tong, X; Wang, J; Wu, J; Yang, F; Zhang, L; Zhang, Q | 1 |
| Aquila, G; Calabria, D; Caliceti, C; Cicero, AFG; Ferrari, R; Fortini, F; Guardigli, M; Hrelia, S; Leoncini, E; Mirasoli, M; Rizzo, B; Rizzo, P; Roda, A; Simoni, P; Zambonin, L | 1 |
| Di Pierro, F; Putignano, P; Villanova, N | 1 |
| Feng, WW; Kuang, SY; Liu, TS; Ma, ZJ; Pang, JY; Tu, C; Wang, JB; Wang, YH; Xiao, XH; Zang, QC; Zhao, YL | 1 |
| Battista, F; Bonaduce, D; Bosso, G; Brambilla, N; D'Amato, M; Fazio, V; Galletti, F; Gentile, M; Giacovelli, G; Mercurio, V; Pucci, G; Schillaci, G; Vitalini, C | 1 |
| Carbone, F; Cremonini, AL; Di Pierro, F; Favari, E; Formisano, E; Pasta, A; Pisciotta, L; Ronca, A; Semino, T; Sukkar, SG | 1 |
| Faggian, M; Marcheluzzo, S; Peron, G; Zancato, M | 1 |
| Arnás, C; Corbella, E; de Dios, S; Florido, M; Licerán, M; Martin, D; Martinez-Martin, F; Petitbò, D; Pintó, X; Sánchez, A; Sánchez-Hernández, RM; Sarasa, I; Trias, F | 1 |
| Ameneiros-Lago, E; Fernández-Fernández, FJ; Sardina-Ferreiro, R | 1 |
| Laffin, LJ; Mirzai, S | 1 |
2 review(s) available for berberine and lovastatin
| Article | Year |
|---|---|
Lipid lowering agents of natural origin: An account of some promising chemotypes.
Topics: Animals; Biological Products; Dyslipidemias; Humans; Hypolipidemic Agents | 2017 |
Supplements for Lipid Lowering: What Does the Evidence Show?
Topics: Animals; Berberine; Dietary Supplements; Humans; Lovastatin; Phytosterols | 2023 |
6 trial(s) available for berberine and lovastatin
| Article | Year |
|---|---|
Effects of a nutraceutical combination on left ventricular remodeling and vasoreactivity in subjects with the metabolic syndrome.
Topics: Anticholesteremic Agents; Berberine; Cardiotonic Agents; Dietary Supplements; Fatty Alcohols; Female; Humans; Insulin Resistance; Lovastatin; Male; Metabolic Syndrome; Middle Aged; Vasodilation; Ventricular Remodeling | 2012 |
Berberine and monacolin effects on the cardiovascular risk profile of women with oestroprogestin-induced hypercholesterolemia.
Topics: Adult; Anticholesteremic Agents; Berberine; Cardiovascular Diseases; Contraception; Contraceptives, Oral; Dietary Supplements; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hypercholesterolemia; Lipid Metabolism; Lovastatin; Norpregnenes; Pilot Projects; Polycystic Ovary Syndrome; Prospective Studies; Risk Factors; Treatment Outcome | 2014 |
Effects of a new combination of nutraceuticals with Morus alba on lipid profile, insulin sensitivity and endotelial function in dyslipidemic subjects. A cross-over, randomized, double-blind trial.
Topics: Aged; Berberine; Biomarkers; Blood Glucose; Cross-Over Studies; Dietary Supplements; Double-Blind Method; Dyslipidemias; Endothelium, Vascular; Female; Glycated Hemoglobin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Insulin; Insulin Resistance; Italy; Lipids; Lovastatin; Male; Middle Aged; Morus; Plant Extracts; Plant Leaves; Time Factors; Treatment Outcome; Vasodilation | 2015 |
Efficacy of a nutraceutical combination on lipid metabolism in patients with metabolic syndrome: a multicenter, double blind, randomized, placebo controlled trial.
Topics: Adult; Aged; Berberine; Cholesterol, LDL; Dietary Supplements; Double-Blind Method; Fatty Alcohols; Female; Humans; Hypertrophy, Left Ventricular; Insulin Resistance; Lipid Metabolism; Lovastatin; Male; Metabolic Syndrome; Middle Aged; Placebos; Treatment Outcome | 2019 |
Efficacy of Nutraceutical Combination of Monacolin K, Berberine, and Silymarin on Lipid Profile and PCSK9 Plasma Level in a Cohort of Hypercholesterolemic Patients.
Topics: Berberine; Dietary Supplements; Humans; Hypercholesterolemia; Lipids; Lovastatin; Proprotein Convertase 9; Silymarin | 2020 |
Effects of treatment with monacolin K, berberine and coenzyme Q10 on lipid metabolism in patients with moderate cardiovascular risk.
Topics: Berberine; Cardiovascular Diseases; Cholesterol, LDL; Dietary Supplements; Heart Disease Risk Factors; Humans; Hypercholesterolemia; Lipid Metabolism; Lovastatin; Risk Factors; Treatment Outcome; Ubiquinone | 2022 |
12 other study(ies) available for berberine and lovastatin
| Article | Year |
|---|---|
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Berberine, a natural cholesterol reducing product, exerts antitumor cytostatic/cytotoxic effects independently from the mevalonate pathway.
Topics: Anticholesteremic Agents; Antineoplastic Agents; Berberine; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Female; Humans; Lovastatin; Mevalonic Acid | 2006 |
Berberine decreases PCSK9 expression in HepG2 cells.
Topics: Anticholesteremic Agents; Berberine; Cell Line; Dactinomycin; Dose-Response Relationship, Drug; Gene Expression Regulation; Humans; Lovastatin; Plant Extracts; Proprotein Convertase 9; Proprotein Convertases; Receptors, LDL; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Serine Endopeptidases; Time Factors; Transcription, Genetic | 2008 |
Antitumor effects of the combination of cholesterol reducing drugs.
Topics: Animals; Anticholesteremic Agents; Antineoplastic Agents; Berberine; Cell Cycle; Cell Line, Tumor; Drug Therapy, Combination; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Mevalonic Acid; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Neoplasms | 2011 |
Effect of Berberine on promoting the excretion of cholesterol in high-fat diet-induced hyperlipidemic hamsters.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Berberine; Cholesterol; Cholesterol, LDL; Cricetinae; Diet, High-Fat; Dietary Fats; Enzyme-Linked Immunosorbent Assay; Extracellular Signal-Regulated MAP Kinases; gamma-Glutamyltransferase; Hyperlipidemias; Lovastatin; Male; Mesocricetus; RNA, Messenger; Time Factors; Triglycerides | 2015 |
Potential Compounds for Oral Cancer Treatment: Resveratrol, Nimbolide, Lovastatin, Bortezomib, Vorinostat, Berberine, Pterostilbene, Deguelin, Andrographolide, and Colchicine.
Topics: Administration, Oral; Algorithms; Antineoplastic Agents; Berberine; Bortezomib; Colchicine; Databases, Pharmaceutical; Databases, Protein; Diterpenes; Humans; Hydroxamic Acids; Limonins; Lovastatin; Models, Statistical; Mouth Neoplasms; Predictive Value of Tests; Resveratrol; Rotenone; Stilbenes; Support Vector Machine; Vorinostat | 2015 |
In Vivo and in Vitro Study on Drug-Drug Interaction of Lovastatin and Berberine from Pharmacokinetic and HepG2 Cell Metabolism Studies.
Topics: Animals; Berberine; Cytochrome P-450 CYP3A; Drug Interactions; Hep G2 Cells; Humans; Lovastatin; Rats | 2016 |
Novel role of the nutraceutical bioactive compound berberine in lectin-like OxLDL receptor 1-mediated endothelial dysfunction in comparison to lovastatin.
Topics: Anti-Inflammatory Agents; Antioxidants; Berberine; Cell Survival; Cells, Cultured; Cytoprotection; Extracellular Signal-Regulated MAP Kinases; Human Umbilical Vein Endothelial Cells; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins, LDL; Lovastatin; Membrane Glycoproteins; NADPH Oxidase 2; NADPH Oxidases; NF-kappa B; Nitric Oxide Synthase Type III; Oxidative Stress; Reactive Oxygen Species; Scavenger Receptors, Class E; Signal Transduction; Tumor Necrosis Factor-alpha | 2017 |
Retrospective analysis of the effects of a highly standardized mixture of Berberis aristata, Silybum marianum, and monacolins K and KA in diabetic patients with dyslipidemia.
Topics: Aged; Berberine; Biological Products; Diabetes Mellitus; Dietary Supplements; Dyslipidemias; Female; Glycated Hemoglobin; Humans; Lipids; Lovastatin; Male; Middle Aged; Retrospective Studies; Silymarin | 2018 |
Natural products berberine and curcumin exhibited better ameliorative effects on rats with non-alcohol fatty liver disease than lovastatin.
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Aspartate Aminotransferases; Berberine; Biological Products; Blood Glucose; Body Weight; Curcumin; Gene Expression Regulation; Inflammation; Insulin; Intra-Abdominal Fat; Lipid Metabolism; Lipids; Lipopolysaccharides; Liver; Lovastatin; Male; Non-alcoholic Fatty Liver Disease; Organ Size; Oxidative Stress; Rats, Sprague-Dawley | 2018 |
Analysis of Monacolins and Berberine in Food Supplements for Lipid Control: An Overview of Products Sold on the Italian Market.
Topics: Berberine; Biological Products; Dietary Supplements; Italy; Lipids; Lovastatin | 2021 |
[Nutraceuticals (monacolin K, berberine and coenzyme Q10) in patients with moderate hypercholesterolemia and low-moderate cardiovascular risk. Potential benefits of combined therapies].
Topics: Berberine; Cardiovascular Diseases; Dietary Supplements; Heart Disease Risk Factors; Humans; Hypercholesterolemia; Lovastatin; Risk Factors | 2023 |